Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-7-25
pubmed:abstractText
Plasma C-terminal atrial natriuretic peptide (C-ANP), N-terminal ANP (N-ANP), and brain natriuretic peptide (BNP) have diagnostic utility in detecting left ventricular dysfunction. Their relative value in monitoring symptom status during the chronic treatment of congestive heart failure (CHF) remains undefined.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1071-9164
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-54
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12140807-Adult, pubmed-meshheading:12140807-Aged, pubmed-meshheading:12140807-Aged, 80 and over, pubmed-meshheading:12140807-Ambulatory Care, pubmed-meshheading:12140807-Atrial Natriuretic Factor, pubmed-meshheading:12140807-Biological Markers, pubmed-meshheading:12140807-Female, pubmed-meshheading:12140807-Heart Failure, pubmed-meshheading:12140807-Humans, pubmed-meshheading:12140807-Male, pubmed-meshheading:12140807-Middle Aged, pubmed-meshheading:12140807-Natriuretic Peptide, Brain, pubmed-meshheading:12140807-Peptide Fragments, pubmed-meshheading:12140807-Protein Precursors, pubmed-meshheading:12140807-Radioimmunoassay, pubmed-meshheading:12140807-Single-Blind Method, pubmed-meshheading:12140807-Treatment Outcome, pubmed-meshheading:12140807-Ventricular Dysfunction, Left
pubmed:year
2002
pubmed:articleTitle
The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
pubmed:affiliation
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't